Option 1: Telehealth Telehealth is the fastest and most convenient route for most Pennsylvania residents
This is why the weight loss is more substantial and sustained than most prior pharmacological approaches
Energy-efficient technology to meet both regulatory and ESG goals
Key findings include: Mean weight loss of 24.2% (approximately 58 pounds or 26.2 kg) with 12 mg weekly dose after 48 weeks Dose-dependent efficacy across 1 mg, 4 mg, 8 mg, and 12 mg dose groups At 48 weeks, 100% of participants receiving 8 mg or 12 mg achieved at least 5% weight loss 93% of participants on 12 mg achieved 15% or more weight loss , far exceeding current therapeutic benchmarks Greater weight reduction observed in participants with BMI greater than or equal to 35 compared to those with BMI below 35 The magnitude of weight loss approaches that typically observed only with bariatric-metabolic surgery, representing a potential paradigm shift in pharmacological obesity treatment[11]
It is difficult to say that one medication universally causes more side effects than the other because the studies involved different people and used different methods
For patients who prefer not to use injections, semaglutide sublingual drops are also available at InjectCo